Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Absci Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ABSI
Nasdaq
8731
https://www.absci.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Absci Corp
10 Penny Stocks That Will Make You A Millionaire
- Jan 10th, 2023 3:36 pm
Absci announces AI breakthrough in designing therapeutic antibodies
- Jan 10th, 2023 3:00 pm
Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI
- Jan 10th, 2023 1:00 pm
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
- Jan 8th, 2023 8:13 pm
Absci (NASDAQ:ABSI) shareholders have endured a 76% loss from investing in the stock a year ago
- Dec 29th, 2022 12:17 pm
Absci to Participate in the Berenberg Discover AI Seminar
- Nov 23rd, 2022 1:00 pm
Absci to Participate in the Piper Sandler Healthcare Conference
- Nov 17th, 2022 1:00 pm
Absci reports $27M loss but strong cash position
- Nov 9th, 2022 3:47 pm
Absci Corporation (ABSI) Reports Q3 Loss, Tops Revenue Estimates
- Nov 9th, 2022 2:15 pm
Absci Reports Third Quarter 2022 Financial Results
- Nov 9th, 2022 1:00 pm
Absci to Participate in the Stifel Healthcare Conference
- Nov 2nd, 2022 8:05 pm
Absci Welcomes Meta Senior Executive to Board of Directors
- Nov 2nd, 2022 12:00 pm
Absci to Participate in the 31st Annual Credit Suisse Healthcare Conference
- Oct 26th, 2022 12:00 pm
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
- Oct 4th, 2022 11:00 am
Institutional owners may consider drastic measures as Absci Corporation's (NASDAQ:ABSI) recent US$46m drop adds to long-term losses
- Sep 28th, 2022 10:44 am
Absci to Participate in the Morgan Stanley Global Healthcare Conference
- Sep 1st, 2022 12:00 pm
Absci to Participate at the Inaugural Gilmartin Group Emerging Growth Company Showcase
- Aug 24th, 2022 11:00 am
Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates
- Aug 11th, 2022 1:15 pm
Absci Reports Second Quarter 2022 Financial Results and Business Update
- Aug 11th, 2022 12:00 pm
The Zacks Analyst Blog Highlights Absci Axcella Health, Freeline Therapeutics Holdings, DICE Therapeutics and Pliant Therapeutics
- Aug 10th, 2022 12:19 pm
Scroll